Man Group’s Arcus Biosciences RCUS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $626K | Sell |
76,919
-25,739
| -25% | -$210K | ﹤0.01% | 1546 |
|
2025
Q1 | $806K | Buy |
102,658
+90,080
| +716% | +$707K | ﹤0.01% | 1427 |
|
2024
Q4 | $187K | Sell |
12,578
-23,362
| -65% | -$348K | ﹤0.01% | 1727 |
|
2024
Q3 | $550K | Buy |
+35,940
| New | +$550K | ﹤0.01% | 1511 |
|
2024
Q1 | – | Sell |
-16,108
| Closed | -$308K | – | 2113 |
|
2023
Q4 | $308K | Buy |
+16,108
| New | +$308K | ﹤0.01% | 1689 |
|
2023
Q2 | – | Hold |
0
| – | -$988K | – | 2126 |
|
2023
Q1 | – | Sell |
-54,099
| Closed | -$1.12M | – | 1326 |
|
2022
Q4 | $1.12M | Buy |
+54,099
| New | +$1.12M | ﹤0.01% | 1283 |
|
2022
Q2 | – | Sell |
-8,403
| Closed | -$265K | – | 2206 |
|
2022
Q1 | $265K | Sell |
8,403
-10,700
| -56% | -$337K | ﹤0.01% | 1760 |
|
2021
Q4 | $773K | Sell |
19,103
-2,849
| -13% | -$115K | ﹤0.01% | 1395 |
|
2021
Q3 | $765K | Sell |
21,952
-8,430
| -28% | -$294K | ﹤0.01% | 1417 |
|
2021
Q2 | $834K | Sell |
30,382
-6,094
| -17% | -$167K | ﹤0.01% | 1420 |
|
2021
Q1 | $1.02M | Buy |
36,476
+21,488
| +143% | +$603K | ﹤0.01% | 1283 |
|
2020
Q4 | $389K | Buy |
+14,988
| New | +$389K | ﹤0.01% | 1602 |
|